EASL 2025 Abstract Highlights
The following highlights showcase late-breaking research presented at the European Association for the Study of the Liver (EASL) Congress 2025.Topics ranged from alanine transaminase testing as a screening tool for paediatric metabolic dysfunction-associated steatotic liver disease to the risks of moderate alcohol use in liver disease, and novel siRNA therapies for hepatitis B.
Publication Details
- Journal
- EMJ Hepatology
- Published
- 2025-06-19
- DOI
- https://doi.org/10.33590/emjhepatol/zgde1257
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00